Literature DB >> 22287725

Role of the apoptotic and mitotic regulator survivin in melanoma.

Jodi A McKenzie1, Douglas Grossman.   

Abstract

Melanoma is the deadliest form of skin cancer. Melanoma develops in response to genetic and environmental pressures which lead to oncogenic transformation of normal human melanocytes, the pigment-producing cells in the body. The majority of melanoma-associated deaths are due to metastases, highlighting the importance of understanding the molecular mechanisms driving melanoma development and progression. This review focuses on survivin, and its involvement in the melanoma biology. Since its identification in the late 1990s, a vast body of work has been generated, demonstrating the role of survivin in various malignancies. This review discusses the established mitotic and cytoprotective properties of survivin, and its potential role in melanoma development and progression. A newly recognized functional property of survivin is also discussed, namely enhancement of cellular motility, which may underlie its role in promoting melanoma metastasis. Finally, various therapeutic strategies targeting survivin in melanoma are reviewed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22287725

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  26 in total

1.  Expression of survivin in adenoid cystic carcinoma of the lacrimal gland and the effect of intervention with arsenic trioxide in vitro.

Authors:  Yingzhe Pan; Yiqiao Xing; Hui Wang
Journal:  Exp Ther Med       Date:  2015-04-30       Impact factor: 2.447

2.  A unique gene expression signature is significantly differentially expressed in tumor-positive or tumor-negative sentinel lymph nodes in patients with melanoma.

Authors:  Ahmad A Tarhini; Theofanis Floros; Hui-Min Lin; Yan Lin; Zahra Rahman; Madeeha Ashraf; Priyanka Vallabhaneni; Cindy Sander; Uma N M Rao; Monica Panelli; William A LaFramboise; John M Kirkwood
Journal:  Melanoma Res       Date:  2017-10       Impact factor: 3.599

3.  miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5.

Authors:  Lina Li; Cuiling Wu; Yue Zhao
Journal:  Oncol Lett       Date:  2017-04-18       Impact factor: 2.967

Review 4.  Association of survivin splice variants with prognosis and treatment of breast cancer.

Authors:  Anastasia Pavlidou; Christos Kroupis; Kleanthi Dimas
Journal:  World J Clin Oncol       Date:  2014-12-10

5.  Gene expression analysis uncovers novel hedgehog interacting protein (HHIP) effects in human bronchial epithelial cells.

Authors:  Xiaobo Zhou; Weiliang Qiu; J Fah Sathirapongsasuti; Michael H Cho; John D Mancini; Taotao Lao; Derek M Thibault; Augusto A Litonjua; Per S Bakke; Amund Gulsvik; David A Lomas; Terri H Beaty; Craig P Hersh; Christopher Anderson; Ute Geigenmuller; Benjamin A Raby; Stephen I Rennard; Mark A Perrella; Augustine M K Choi; John Quackenbush; Edwin K Silverman
Journal:  Genomics       Date:  2013-03-01       Impact factor: 5.736

6.  The expression and function of microRNA-203 in lung cancer.

Authors:  Jianhua Jin; Jianzhong Deng; Fang Wang; Xiyi Xia; Tiefeng Qiu; Wenbin Lu; Xianwen Li; Hua Zhang; Xiaoyan Gu; Yungang Liu; Weiguo Cao; Wenlong Shao
Journal:  Tumour Biol       Date:  2012-10-17

7.  Vemurafenib synergizes with nutlin-3 to deplete survivin and suppresses melanoma viability and tumor growth.

Authors:  Zhenyu Ji; Raj Kumar; Michael Taylor; Anpuchchelvi Rajadurai; Alexander Marzuka-Alcalá; Y Erin Chen; Ching-Ni Jenny Njauw; Keith Flaherty; Göran Jönsson; Hensin Tsao
Journal:  Clin Cancer Res       Date:  2013-06-27       Impact factor: 12.531

8.  Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells.

Authors:  Weiguo Cao; Rong Fan; Lifu Wang; Shidan Cheng; Hao Li; Jinsong Jiang; Mei Geng; Yening Jin; Yunlin Wu
Journal:  Tumour Biol       Date:  2012-12-22

9.  The cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effects.

Authors:  Maryam Zamanian-Daryoush; Daniel Lindner; Thomas C Tallant; Zeneng Wang; Jennifer Buffa; Elizabeth Klipfell; Yvonne Parker; Denise Hatala; Patricia Parsons-Wingerter; Pat Rayman; Mohamed Sharif S Yusufishaq; Edward A Fisher; Jonathan D Smith; Jim Finke; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2013-05-17       Impact factor: 5.157

10.  Discovery of novel second mitochondria-derived activator of caspase mimetics as selective inhibitor of apoptosis protein inhibitors.

Authors:  Jin Wang; Wei Li
Journal:  J Pharmacol Exp Ther       Date:  2014-03-12       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.